|
|
(46 intermediate revisions not shown) |
Line 26: |
Line 26: |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> |
- | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Symbiosis confirmation by co-culture </a></li> | + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Mutualism Confirmation ~Co-culture Assay~</a></li> |
| | | |
| </ul> | | </ul> |
Line 72: |
Line 72: |
| <p align="center"><span class="title-small">Contents</span></p> | | <p align="center"><span class="title-small">Contents</span></p> |
| <p align="left" class="info-24"><a href="#1">1. Introduction </a></p> | | <p align="left" class="info-24"><a href="#1">1. Introduction </a></p> |
- | <p align="left" class="info-24"><a href="#2">2. Summary of the experiments </a></p> | + | <p align="left" class="info-24"><a href="#2">2. Summary of the Experiments </a></p> |
| <p align="left" class="info-18"><a href="#2.1">2.1 C4HSL-dependent CmR expression</a></p> | | <p align="left" class="info-18"><a href="#2.1">2.1 C4HSL-dependent CmR expression</a></p> |
| <p align="left" class="info-18"><a href="#2.2">2.2 C4HSL-dependent 3OC12HSL production </a></p> | | <p align="left" class="info-18"><a href="#2.2">2.2 C4HSL-dependent 3OC12HSL production </a></p> |
Line 78: |
Line 78: |
| <p align="left" class="info-18"><a href="#3.1">3.1. C4HSL-Dependent CmR Expression Assay</a></p> | | <p align="left" class="info-18"><a href="#3.1">3.1. C4HSL-Dependent CmR Expression Assay</a></p> |
| <p align="left" class="info-18"><a href="#3.2">3.2. C4HSL-Dependent 3OC12HSL Production Assay</a></p> | | <p align="left" class="info-18"><a href="#3.2">3.2. C4HSL-Dependent 3OC12HSL Production Assay</a></p> |
- | <p align="left" class="info-24"><a href="#4">4. Materials and methods</a></p> | + | <p align="left" class="info-24"><a href="#4">4. Materials and Methods</a></p> |
| <p align="left" class="info-18"><a href="#4.1">4.1. Construction</a></p> | | <p align="left" class="info-18"><a href="#4.1">4.1. Construction</a></p> |
| <p align="left" class="info-18"><a href="#4.2">4.2. Assay Protocol </a></p> | | <p align="left" class="info-18"><a href="#4.2">4.2. Assay Protocol </a></p> |
Line 96: |
Line 96: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">We designed signal-dependent signal production in our system by using signaling molecules and antibioticss resistance gene. In our bank story, we used signaling molecules C4HSL as money.</p></td> | + | <td colspan="2"><p class="info-18">We designed signal-dependent signal production in our system by using signaling molecules and antibiotics resistance gene. In our bank story, we used signaling molecule C4HSL as money.</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">For construction of the C4HSL-dependent chloramphenicol resistance (CmR) and 3OC12HSL production module, we constructed a new part Prhl(RL)-CmR-LasI(<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>). Prhl(RL)-CmR-LasI cell is an engineered <i>E. coli</i> that contains a C4HSL-dependent LasI generator and a constitutive RhlR generator. As a constitutive RhlR generator, we used Ptet-RhlR. In our bank story, this part imitates the functions of Company. (Fig. 3-3-1-1.) We confirmed that C4HSL-depedent growth by measuring optical density, and C4HSL-dependent 3OC12HSL production by using reporter cell. </p> </td> | + | <td colspan="2"><p class="info-18">For construction of the C4HSL-dependent chloramphenicol resistance gene product(CmR) and 3OC12HSL production module, we constructed a new part Prhl(RL)-CmR-LasI(<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>). Prhl(RL)-CmR-LasI cell is an engineered <i>E. coli</i> that contains a C4HSL-dependent LasI generator and a constitutive RhlR generator. As a constitutive RhlR generator, we used Ptet-RhlR. In our bank story, this part imitates the functions of Company. (Fig. 3-3-1-1) We confirmed the C4HSL-dependent growth by measuring optical density, and C4HSL-dependent 3OC12HSL production by using reporter cell. </p> </td> |
| </tr> | | </tr> |
| | | |
Line 109: |
Line 109: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-1-1 Genetic Circuit of Company <i>E. coli</i></div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-1-1.</strong> Genetic Circuit of Company <i>E. coli</i></div></td> |
| </tr> | | </tr> |
| | | |
Line 135: |
Line 135: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td width="445"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-1-2.png"><img src="https://static.igem.org/mediawiki/2014/thumb/9/9a/Tokyo_Tech_3-3-1-2.png/742px-Tokyo_Tech_3-3-1-2.png" width="300" /></a></div></td> | + | <td width="445"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-1-2.png"><img src="https://static.igem.org/mediawiki/2014/9/9a/Tokyo_Tech_3-3-1-2.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center">Fig. 3-3-2-1. C4HSL-depemdent CmR expression Assay Flow Chart</div></td> | + | <td><div align="center"><strong>Fig. 3-3-2-1.</strong> Flow chart of C4HSL-dependent CmR expression assay</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 144: |
Line 144: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18"> We confirmed the function of C4HSL-dependent CmR expression by measuring optical density of the cell cultures containing chloramphenicol. </a></td> | + | <td colspan="2"><p class="info-18"> We confirmed the function of C4HSL-dependent CmR expression by measuring optical density of the cultures containing chloramphenicol(Fig. 3-3-2-1). </a></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">In this experiment we prepared three plasmids, A, B and C. (See Fig. 3-4-2-1.) Right after the C4HSL induction, we added chloramphenicol into the medium containing Company cell. We measured optical density for about 8 h to estimate the concentration of the cell.</a> | + | <td colspan="2"><p class="info-18">In this experiment we prepared three plasmids, A, B and C. (See Fig. 3-3-2-2) Right after the C4HSL induction, we added chloramphenicol into the medium containing Company cell. We measured the optical density for about eight hours to estimate the concentration of the cell.</a> |
| </p> </td> | | </p> </td> |
| </tr> | | </tr> |
Line 154: |
Line 154: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center">Fig. 3-3-2-2. Plasmids for the experiment of C4HSL-dependent CmR expression図がない</div></td>
| + | <tr><td colspan="2"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-2-2-1.png"><img src="https://static.igem.org/mediawiki/2014/9/9d/Tokyo_Tech_3-3-2-2-1.png" width="400" /></a></div></td> |
| </tr> | | </tr> |
| + | <td><div align="center"><strong>Fig. 3-3-2-2.</strong> Plasmids for the experiment of C4HSL-dependent CmR expression</div></td> |
| + | </tr> |
| + | </tr> |
| + | <tr> |
| + | |
| <tr> | | <tr> |
| <td colspan="2"> </td> | | <td colspan="2"> </td> |
Line 166: |
Line 171: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td width="445"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-1-3.png"><img src="https://static.igem.org/mediawiki/2014/thumb/4/45/Tokyo_Tech_3-3-1-3.png/800px-Tokyo_Tech_3-3-1-3.png" width="300" /></a></div></td>
| + | <td colspan="2"><p class="info-18">We performed a reporter assay by using reporter cells to characterize the function of C4HSL-dependent C4HSL production. Prhl(RL)-CmR-LasI cell containing constitutive RhlR generator expresses LasI and produces 3OC12HSL in the presence of C4HSL. Since 3OC12HSL is excreted to the culture, the supernatant of the sender cell contains 3OC12HSL when the part works as expected. </p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center">Fig. 3-3-1-3. Flow chart of C4HSL-dependent 3OC12HSL <br />
| + | <td colspan="2"><p class="info-18"> Reporter cells are incubated in the supernatant of the culture of sender cells. When there are 3OC12HSL in the supernatant, reporter cell expresses GFP. We checked the fluorescence of reporter cells to confirm the expression of 3OC12HSL. The expression of the reporter cells were measured by flow cytometer.(See Fig.3-3-2-3)</p></td> |
- | production Assay </div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td colspan="2"><p class="info-18">We performed a reporter assay by using reporter cells to characterize the function of C4HSL-dependent C4HSL production. Prhl(RL)-CmR-LasI cell containing constitutive RhlR generator expresses LasI and produces 3OC12HSL in the presence of C4HSL. Since 3OC12HSL is excreted to the culture, the supernatant of the sender cell contains 3OC12HSL when the part works as expected. </p></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td colspan="2"><p class="info-18"> Reporter cells are incubated in the supernatant of the culture of sender cells. When there are 3OC12HSL in the supernatant, reporter cell expresses GFP. We checked the fluorescence of reporter cells to confirm of the expression of 3OC12HSL.The expression of the reporter cells were measured by Flow Cytometer.</p></td> | + | |
| </tr><tr> | | </tr><tr> |
| <td colspan="2"> </td> | | <td colspan="2"> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">We prepared the following conditions for the induction of reporter cells. (Plux-CmR cell was used as the negative control.)</p></td> | + | <td width="445"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-1-3.png"><img src="https://static.igem.org/mediawiki/2014/4/45/Tokyo_Tech_3-3-1-3.png" width="500" /></a></div></td> |
| + | </tr> |
| + | <tr> |
| + | <td><div align="center"><strong>Fig. 3-3-2-3. </strong>Flow chart of C4HSL-dependent 3OC12HSL production Assay </div></td> |
| + | </tr> |
| + | |
| + | <tr><td colspan="2"><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_3-3-2-2.png"><img src="https://static.igem.org/mediawiki/2014/2/2f/Tokyo_Tech_3-3-2-2.png" width="700" /></a></div></td> |
| + | </tr> |
| + | <td><div align="center"><strong>Fig. 3-3-2-4.</strong>Plasmids for the experiment of C4HSL-dependent 3OC12HSL production</div></td> |
| + | </tr> |
| + | |
| + | <td colspan="2"><p class="info-18">We prepared the following conditions for the induction of reporter cells. (Plux-CmR cell was used as the negative control. See Fig. 3-3-2-4)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 196: |
Line 205: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">(5) 5 microM of artificial C4HSL in LB medium </p></td> | + | <td colspan="2"><p class="info-18">(5) 5 microM of synthetic C4HSL in LB medium </p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 238: |
Line 247: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">We tested two type of culture condition which contains different concentration of chloramphenicol(Cm). (0 and 100 microg / mL)</p></td> | + | <td colspan="2"><p class="info-18">We tested two types of culture condition which contains different concentration of chloramphenicol(Cm). (0 and 100 microg / mL)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">Fig.3-3-3-1. Fig.3-3-3-2. shows the condition in the absence and presence of chloramphenicol, respectively. </p></td> | + | <td colspan="2"><p class="info-18">Fig.3-3-3-1, Fig.3-3-3-2 shows the condition in the absence and presence of chloramphenicol, respectively. </p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 254: |
Line 263: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-3-1. C4HSL-Dependent Company Growth in no Cm</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-3-1.</strong> C4HSL-Dependent Company growth with no Cm addition</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 263: |
Line 272: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-3-2. C4HSL-Dependent Company Growth in 100 microg/mL Cm</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-3-2.</strong> C4HSL-Dependent Company Growth in 100 microg/mL Cm</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 275: |
Line 284: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><h1>3-2. C4HSL-dependent 3OC12HSL production Assay</h1></td> | + | <td colspan="2"><h1>3-2. C4HSL-dependent 3OC12HSL Production Assay</h1></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><p class="info-18">Fig. 3-3-3-3. shows the fluorescence intensities generated by reporter cells. When the reporter cell E was incubated in the condition (1) (the culture of the induced Company cell), the fluorescence intensity of the reporter cell increased. Comparing the results of condition (1) and (2) reporter cell in the supernatant of (1) had 29-fold higher fluorescence intensity. </p></td> | + | <td colspan="2"><p class="info-18">Fig. 3-3-3-3 shows the fluorescence intensities generated by the reporter cells. When the reporter cell E was incubated in the condition (1) (the culture of the induced Company cell), the fluorescence intensity of the reporter cell increased. Comparing the results of condition (1) and (2) reporter cell in the supernatant of (1) had 29-fold higher fluorescence intensity. </p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 293: |
Line 302: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center"><a href="#"><img src="" width="500" /></a></div></td> | + | <td colspan="2"><div align="center"><a href="https://2014.igem.org/File:Customer excretes 3OC12HSL when C4HSL exists.png"><img src="https://static.igem.org/mediawiki/2014/0/07/Customer_excretes_3OC12HSL_when_C4HSL_exists.png" width="500" /></a></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-3-3. Customer excretes 3OC12HSL when C4HSL exists</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-3-3.</strong> Company excretes 3OC12HSL when C4HSL exists</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 336: |
Line 345: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"><div align="left">A. Ptet-GFP-Ptet-RhlR (psB6A1), Prhl(RL)-CmR-LasI(pSB3K3)</div></td> | + | <td colspan="2" class="info-18"><div align="left">A. Ptet-GFP-Ptet-RhlR (pSB6A1), Prhl(RL)-CmR-LasI(pSB3K3)</div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 345: |
Line 354: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-1.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-1.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 351: |
Line 360: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">B. Ptet-GFP-Ptet-RhlR (psB6A1), PlacIq-CmR (pSB3K3)…Positive control</td> | + | <td colspan="2" class="info-18">B. Ptet-GFP-Ptet-RhlR (pSB6A1), PlacIq-CmR (pSB3K3)…Positive control</td> |
- | </tr> | + | </tr |
| <tr> | | <tr> |
| <td colspan="2"> </td> | | <td colspan="2"> </td> |
Line 360: |
Line 369: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-2.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-2.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 375: |
Line 384: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-3.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-3.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 399: |
Line 408: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-4.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-4.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 414: |
Line 423: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-5.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-5.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 435: |
Line 444: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-6図が違う.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-6.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 441: |
Line 450: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">F. Ptet-LuxR (pSB6A1), PlacIq-GFP (pSB3K3) (Positive control)</td> | + | <td colspan="2" class="info-18">F. Ptet-LuxR (pSB6A1), PlacIq-GFP (pSB3K3)...Positive control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 450: |
Line 459: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-7.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-7.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 456: |
Line 465: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">G. Ptet-LuxR (pSB6A1), Promoter-less-GFP (pSB3K3) (Negative control)</td> | + | <td colspan="2" class="info-18">G. Ptet-LuxR (pSB6A1), Promoter-less-GFP (pSB3K3)...Negative control</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 465: |
Line 474: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><div align="center">Fig. 3-3-4-8.</div></td> | + | <td colspan="2"><div align="center"><strong>Fig. 3-3-4-8.</strong></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 478: |
Line 487: |
| | | |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">1. Grow the colony of sender cell in LB containing antibiotic O/N at 37°C.</td> | + | <td colspan="2" class="info-18">1. Prepare overnight cultures for the sender cells in 3 mL LB medium, containing ampicillin (50 microg / mL) and kanamycin (30 microg / mL) at 37°C for 12h.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 488: |
Line 497: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 1) 3 mL of LB containing Amp and Kan + 3 microL C4HSL (5 microM)</td> | + | <td colspan="2" class="info-18"> 1) 3 mL of LB containing Amp and Kan + 30 microL C4HSL (final concentration is 5 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 2) 3 mL of LB containing Amp and Kan + 3 microL DMSO</td> | + | <td colspan="2" class="info-18"> 2) 3 mL of LB containing Amp and Kan + 30 microL DMSO</td> |
| </tr> | | </tr> |
| | | |
| <tr> | | <tr> |
| <td colspan="2" class="info-18"> 3) 3 mL of LB containing Amp, Kan and Cm (final concentration is 100 microg/mL) <br /> | | <td colspan="2" class="info-18"> 3) 3 mL of LB containing Amp, Kan and Cm (final concentration is 100 microg/mL) <br /> |
- | + 30 microL C4HSL (500 microM)</td> | + | + 30 microL C4HSL (final concentration is 500 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 4) 3 mL of LB containing Amp, Kan and Cm (final concentration is 100 microg/mL) + 30 microL DMSO</td> | + | <td colspan="2" class="info-18"> 4) 3 mL of LB containing Amp, Kan and Cm (final concentration of Cm is 100 microg/mL) + 30 microL DMSO</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 505: |
Line 514: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">5. Measure optical density every hour. (If optical density is over 1.0, dilute the cell medium to 1/10.)</td> | + | <td colspan="2" class="info-18">5. Measure optical density every hour. (If the optical density is over 1.0, dilute the cell medium to 1/10.)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 518: |
Line 527: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">1. Grow the colony of sender cell in LB containing antibiotic O/N at 37°C.</td> | + | <td colspan="2" class="info-18">1. Prepare overnight cultures for the sender cells in 3 mL LB medium, containing ampicillin (50 microg / mL) and kanamycin (30 microg / mL) at 37°C for 12h. </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5.If the OD becomes over 0.5, dilute to o.5 with LB medium.</td> | + | <td colspan="2" class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 527: |
Line 536: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> a) Add 15 microL of 10 microM C4HSL to 3 mL LB containing Amp and Kan</td> | + | <td colspan="2" class="info-18"> a) Add 15 microL of 10 mM C4HSL to 3 mL LB containing Amp and Kan (final concentration is 50 microM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 536: |
Line 545: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">5. Measure optical density every hour. (If optical density is over 1.0, dilute the cell medium to 1/10.)</td> | + | <td colspan="2" class="info-18">5. Measure the optical density every hour. (If the optical density is over 1.0, dilute the cell medium to 1/10.)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">6. Centrifuge sample at 9000x g, 4°C for 1minute.Filter sterilize supernatant. (Pore size is 0.22 microm.)</td> | + | <td colspan="2" class="info-18">6. Centrifuge the sample at 9000x g, 4°C for 1 min. Filter sterilize the supernatant. (Pore size is 0.22 microm.)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 551: |
Line 560: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">1. Grow the colony of Reporter cell (E~G) in LB containing antibiotic(Amp and Kan) over night at 37°C.</td> | + | <td colspan="2" class="info-18">1. Prepare overnight cultures for the Reporter cell (E~G) in 3 mL LB medium, containing ampicillin (50 microg / mL) and kanamycin (30 microg / mL) at 37°C for 12h.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB+ antibiotic and grow the cells at 37°C until you reach an 0.5 in OD590 (fresh culture).</td> | + | <td colspan="2" class="info-18">2. Make a 1:100 dilution in 3 mL of fresh LB + antibiotic and grow the cells at 37°C until you reach an 0.5 in OD590 (fresh culture).</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 560: |
Line 569: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 1)2.7 mL filtrate of Aa +300 microL LB </td> | + | <td colspan="2" class="info-18"> 1) 2.7 mL filtrate of Aa +300 microL LB </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 2)2.7 mL filtrate of Ab +300 microL LB</td> | + | <td colspan="2" class="info-18"> 2) 2.7 mL filtrate of Ab +300 microL LB</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 572: |
Line 581: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 5)3 mL LB + 500 microM C12HSL 30 microL (final concentration is 5 microM)</td> | + | <td colspan="2" class="info-18"> 5) 3 mL LB + 5 microM C12HSL 3 microL (Final concentration is 5 nM)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18"> 6)3 mL LB + DMSO 30 microL </td> | + | <td colspan="2" class="info-18"> 6) 3 mL LB + DMSO 3 microL </td> |
| </tr> | | </tr> |
| | | |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">4. Grow the samples of Reporter cell in incubator at 37°C for 4 hours.</td> | + | <td colspan="2" class="info-18">4. Grow the samples of Reporter cell in incubator at 37°C for 4 h.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">5. Start preparing the flow cytometer 1 h before the end of incubation.</td> | + | <td colspan="2" class="info-18">5. Start preparing the flow cytometer 1 h before the end of incubation.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">6. After incubation, take the sample, and centrifuge at 9000x g, 1 min, 4°C.</td> | + | <td colspan="2" class="info-18">6. After the incubation, take the sample, and centrifuge at 9000x g, 1 min., 4°C.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">7. Remove the supernatant by using P1000 pipette.</td> | + | <td colspan="2" class="info-18">7. Remove the supernatant by using P1000 pipette.</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="info-18">8. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3.)</td> | + | <td colspan="2" class="info-18">8. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3.)</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |